Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

2.05
Delayed Data
As of Feb 22
 -0.05 / -2.38%
Today’s Change
1.78
Today|||52-Week Range
6.93
-2.38%
Year-to-Date

Today’s Trading

Previous close2.10
Today’s open2.05
Day’s range2.05 - 2.14
Volume148,785
Average volume (3 months)287,960
Market cap$62.8M
Dividend yield--
Data as of 4:00pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)-29.52%
Earnings growth (next 5 years)--
Revenue growth (last year)+11.65%
P/E ratioNM
Price/Sales456.64
Price/Book1.25

Competitors

 Today’s
change
Today’s
% change
CDNACareDx Inc0.000.00%
ONCSOncoSec Medical Inc+0.12+8.57%
TROVUTrovagene Inc0.000.00%
PMDPsychemedics Corp+0.52+2.53%
Data as of 02/22/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$312.8K
Annual profit (last year)-$27.5M
Net profit margin-8,781.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Bill Welch
Vice President-Finance &
Administration
Elizabeth Anderson
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs